DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Healthcare
Author Program NEWCreate Narrative
FORTIS logo

Fortis Healthcare Limited Stock Price

NSEI:FORTIS Community·₹681.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 12 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

FORTIS Share Price Performance

₹902.45
-63.50 (-6.57%)
​
₹1,104.89
Fair Value
₹902.45
-63.50 (-6.57%)
18.3% undervalued intrinsic discount
₹1,104.89
Fair Value
Price ₹902.45
AnalystConsensusTarget ₹1,104.89
Tue, 23 Jun 26
Fair Value₹1,104.89
Share Pricen/a

FORTIS Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value ₹1.1k 18.3% undervalued intrinsic discount

Expanding Capacity And Specialty Care Will Transform India's Healthcare Landscape

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
FORTIS logo
Fortis Healthcare
18.3% undervalued intrinsic discount

Expanding Capacity And Specialty Care Will Transform India's Healthcare Landscape

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 23 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
FORTIS logo

FORTIS: Upcoming Board Meeting And Dividend Decision Will Drive Future Upside

Fair Value: ₹1.1k 18.3% undervalued intrinsic discount
6 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Reasonable growth potential with proven track record.

0 Risks
3 Rewards
View Full Analysis

Fortis Healthcare Limited Key Details

₹95.1b

Revenue

₹38.6b

Cost of Revenue

₹56.5b

Gross Profit

₹46.0b

Other Expenses

₹10.5b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
13.88
59.39%
11.02%
34.2%
View Full Analysis

About FORTIS

Founded
1996
Employees
14649
CEO
Ashutosh Raghuvanshi
WebsiteView website
www.fortishealthcare.com

Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company services in the areas of cardiac science, nephrology, diabetology/endocrinology, foetal medicine, infectious diseases, mental health and behavioral science, oncology, orthopedics, physiotherapy and rehabilitation, rheumatology, urology, nuclear medicine, critical care, emergency and trauma, general surgery, internal medicine, neurointerventional radiology, obstetrics and gynaecology, pediatrics, pediatrics, vascular surgery, and support facilities. It also provides services in the areas of infertility medicine, dental science, endocrine surgery, geriatric medicine, liver transplant and hepatobiliary sciences, neurology, ophthalmology, pain and palliative medicine, pulmonology, thoracic surgery, gastroenterology sciences, dermatology, ENT, haematology, medical generics, neurology, organ transplant, radiology, and transfusion medicines. In addition, the company offers various spectrum integrated healthcare services ranging from clinics to quaternary care facilities and a range of ancillary services, as well as secondary, and tertiary care services. The company’s healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. Fortis Healthcare Limited was incorporated in 1996 and is based in Gurugram, India.

Recent FORTIS News & Updates

Analysis Article • Aug 09

Earnings Miss: Fortis Healthcare Limited Missed EPS By 7.1% And Analysts Are Revising Their Forecasts

Fortis Healthcare Limited ( NSE:FORTIS ) came out with its quarterly results last week, and we wanted to see how the...

Recent updates

No updates

Fortis Healthcare Limited Competitors

View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide